BRAIN AND GASTROINTESTINAL CHOLECYSTOKININ RECEPTOR FAMILY - STRUCTURE AND FUNCTIONAL EXPRESSION

被引:452
作者
WANK, SA
PISEGNA, JR
DEWEERTH, A
机构
[1] Digestive Diseases Branch, NIDDKD, National Institutes of Health, Bethesda
关键词
GASTROINTESTINAL PEPTIDE RECEPTOR; NEUROPEPTIDE RECEPTOR; GUANINE NUCLEOTIDE-BINDING REGULATORY PROTEIN-COUPLED RECEPTOR;
D O I
10.1073/pnas.89.18.8691
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cholecystokinin was one of the first gastrointestinal peptides discovered in the mammalian brain. In the central nervous system there is evidence for CCK(A) and CCK(B) receptor subtypes. The CCK(A) receptors occur in a few localized areas of the central and peripheral nervous systems where they modulate feeding and dopamine-induced behavior. CCK(B) receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. We have recently purified and cloned a CCK(A) receptor cDNA from rat pancreas that allowed isolation of an identical cDNA from rat brain by using the polymerase chain reaction. Using low-stringency hybridization screening of cDNA libraries from rat brain and AR42-J cells, which possess large numbers of CCK(B) receptors, we identified previously unreported cDNAs, the sequence of which were identical in both tissues. The cDNA sequence encodes a 452-amino acid protein that is 48% identical to the CCK(A) receptor and contains seven transmembrane domains characteristic of guanine nucleotide-binding regulatory protein-coupled receptors. COS-7 cells transfected with this cDNA expressed binding sites for agonists and antagonists characteristic of a CCK(B) receptor subtype. We conclude that this cDNA isolated from rat brain and AR42-J cells is a receptor of the CCK(B) subtype and that the respective cDNAs for both CCK(A) and CCK(B) are identical in the brain and gastrointestinal system.
引用
收藏
页码:8691 / 8695
页数:5
相关论文
共 46 条
[1]   MOLECULAR-CLONING OF THE BOMBESIN GASTRIN-RELEASING PEPTIDE RECEPTOR FROM SWISS 3T3 CELLS [J].
BATTEY, JF ;
WAY, JM ;
CORJAY, MH ;
SHAPIRA, H ;
KUSANO, K ;
HARKINS, R ;
WU, JM ;
SLATTERY, T ;
MANN, E ;
FELDMAN, RI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :395-399
[2]   RECEPTORS ON SMOOTH-MUSCLE CELLS - CHARACTERIZATION BY CONTRACTION AND SPECIFIC ANTAGONISTS [J].
BITAR, KN ;
MAKHLOUF, GM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (04) :G400-G407
[4]   CHOLECYSTOKININ-DOPAMINE INTERACTIONS [J].
CRAWLEY, JN .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (06) :232-236
[5]  
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[6]  
Davis L. G., 1986, BASIC METHODS MOL BI
[7]   A COMPREHENSIVE SET OF SEQUENCE-ANALYSIS PROGRAMS FOR THE VAX [J].
DEVEREUX, J ;
HAEBERLI, P ;
SMITHIES, O .
NUCLEIC ACIDS RESEARCH, 1984, 12 (01) :387-395
[8]   STRUCTURAL FEATURES REQUIRED FOR LIGAND-BINDING TO THE BETA-ADRENERGIC-RECEPTOR [J].
DIXON, RAF ;
SIGAL, IS ;
CANDELORE, MR ;
REGISTER, RB ;
SCATTERGOOD, W ;
RANDS, E ;
STRADER, CD .
EMBO JOURNAL, 1987, 6 (11) :3269-3275
[9]   IMMUNOCHEMICAL EVIDENCE OF CHOLECYSTOKININ-LIKE PEPTIDES IN BRAIN [J].
DOCKRAY, GJ .
NATURE, 1976, 264 (5586) :568-570
[10]   THE SELECTIVE CCK-B RECEPTOR ANTAGONIST L-365,260 ENHANCES MORPHINE ANALGESIA AND PREVENTS MORPHINE-TOLERANCE IN THE RAT [J].
DOURISH, CT ;
ONEILL, MF ;
COUGHLAN, J ;
KITCHENER, SJ ;
HAWLEY, D ;
IVERSEN, SD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 176 (01) :35-44